Viro Pharma
ViroPharma Incorporated, a pharmaceutical company, develops and sells drugs that address serious diseases treated by physician specialists and in hospital settings. The company focuses on product development activities on virus#Viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections.
The company has strategic relationships with GlaxoSmithKline, Schering-Plough, and Sanofi-Aventis. ViroPharma acquired Lev Pharmaceuticals in a merger on 10/21/2008.
ViroPharma is a member of the NASDAQ Biotechnology Index and the S&P 600.
Read more about Viro Pharma: History, Board of Directors, Management Team